MetaCap

MBX Biosciences Insider Trades

NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

53.24-0.01 (-0.02%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $1.06M
Sales
5 · $2.73M
Shares bought / sold
58.50K / 71.21K
Net activity
Net selling $1.7 million

MBX Biosciences insider activity

Over the last 12 months, MBX Biosciences insiders reported 18 transactions on SEC Form 4: 3 open-market purchases and 5 sales. Insiders bought $1.1 million and sold $2.7 million worth of stock, for net insider selling of $1.7 million. The largest seller was Azoulay Salomon, with $2.7 million in reported sales.

The most recent filing shows Azoulay Salomon (Chief Medical Officer) selling 370 shares at $65.77 on Aug 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MBX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

MBX insider transactions

MBX Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Aug 4, 2026Azoulay SalomonChief Medical OfficerSale370$24.33KForm 4
Aug 3, 2026Hoerter Steven L.President and CEOAward71,000—Form 4
Aug 3, 2026Smither John WChief Financial OfficerAward28,000—Form 4
May 8, 2026Azoulay SalomonChief Medical OfficerSale15,003$574.61KForm 4
May 8, 2026Azoulay SalomonChief Medical OfficerOption exercise15,003$240.05KForm 4
May 8, 2026Azoulay SalomonChief Medical OfficerSale55,000$2.11MForm 4
May 8, 2026Azoulay SalomonChief Medical OfficerOption exercise55,000$575.30KForm 4
May 6, 2026Hawryluk P. KentPresident & CEOSale607$17.93KForm 4
May 6, 2026Azoulay SalomonChief Medical OfficerSale231$6.82KForm 4
May 1, 2026Hoerter Steven L.DirectorAward11,938—Form 4
Mar 13, 2026Hawryluk P. KentPresident & CEOBuy18,500$525.66KForm 4
Feb 26, 2026Hawryluk P. KentPresident & CEOOption exercise28,768$460.29KForm 4
Feb 2, 2026Hawryluk P. KentPresident & CEOAward35,250—Form 4
Feb 2, 2026Bartram RichardChief Financial OfficerAward15,000—Form 4
Feb 2, 2026Azoulay SalomonChief Medical OfficerAward15,000—Form 4
Oct 24, 2025Hawryluk P. KentPresident & CEOOption exercise182,859$594.29KForm 4
Oct 20, 2025Hawryluk P. KentPresident & CEOBuy20,000$272.79KForm 4
Oct 17, 2025Hoerter Steven L.DirectorBuy20,000$264.98KForm 4
Sep 26, 2025Heron Patrick J & FHMLS X, L.P. & FHMLS X, L.L.C. & Topper James N & Frazier Life Sciences X, L.P.DirectorBuy666,666$12.00MForm 4
Apr 8, 2025Pescovitz Ora H.DirectorBuy7,693$45.31KForm 4
Feb 18, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirectorBuy94,100$1.02MForm 4
Feb 18, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirectorBuy49,070$531.92KForm 4
Feb 18, 2025GORDON CARL LDirectorBuy94,100$1.02MForm 4
Feb 18, 2025GORDON CARL LDirectorBuy49,070$531.92KForm 4
Feb 14, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirectorBuy29,540$290.97KForm 4
Feb 14, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirectorBuy17,962$177.82KForm 4
Feb 14, 2025GORDON CARL LDirectorBuy29,540$290.97KForm 4
Feb 14, 2025GORDON CARL LDirectorBuy17,962$177.82KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related